Here’s Apple’s 916-page appeal over the Apple Watch ban
There was no question that Apple would appeal when the International Trade Commission banned Apple Watch Series 9 and Ultra 2 sales last year.
the Apple Watch ban centers around whether Apple infringed upon medical device-maker Masimo’s pulse oximetry patents.
The ITC sided with Masimo, concluding that Apple had infringed their patents, and that the infringement was harming domestic industry.
Not to get too into the weeds, but a good chunk of Apple’s appeal argues:
The appeal brief claims that not only was Masimo primarily known for clinical pulse oximeters, it didn’t even have an actual smartwatch when the complaint was filed.
The smartwatch in question is Masimo’s W1 smartwatch, which launched in 2022.
Masimo filed with the ITC in 2021, and according to Apple’s brief, Masimo only provided CAD drawings as evidence.
The 916 pages filed today include a 68 page brief, the 300+ page ITC decision being appealed, hundreds of eye-watering pages from the Patent Office, and more.
Apple has gotten around the import ban by selling modified versions of the Apple Watch Series 9 and Ultra 2 that disables the blood oxygen tech.